Application 219049
- Type
- ANDA
- Sponsor
- QILU
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CYCLOSPORINE | CYCLOSPORINE | CAPSULE;ORAL | 25MG | No | No |
| 002 | CYCLOSPORINE | CYCLOSPORINE | CAPSULE;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219049-001 | CYCLOSPORINE | CYCLOSPORINE | 25MG | CAPSULE / ORAL | AB1 | 2025-09-15 | |
| A219049-002 | CYCLOSPORINE | CYCLOSPORINE | 100MG | CAPSULE / ORAL | AB1 | 2025-09-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219049-001 | AB1 |
| A219049-002 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219049-001 | CYCLOSPORINE | 25MG | CAPSULE / ORAL | AB1 | 2025-09-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219049-002 | CYCLOSPORINE | 100MG | CAPSULE / ORAL | AB1 | 2025-09-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219049-001 | CYCLOSPORINE | 25MG | CAPSULE / ORAL | AB1 | 2025-09-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219049-002 | CYCLOSPORINE | 100MG | CAPSULE / ORAL | AB1 | 2025-09-15 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219049-001 | CYCLOSPORINE | 25MG | CAPSULE / ORAL | AB1 | 2025-09-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219049-002 | CYCLOSPORINE | 100MG | CAPSULE / ORAL | AB1 | 2025-09-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219049-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219049-002 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219049-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219049-002 | AB1 | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219049-001 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219049-002 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neoral | CYCLOSPORINE | Novartis Pharmaceuticals Corporation | 94461af3-11f1-4670-95d4-2965b9538ae3 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | CYCLOSPORINE |
| Sandimmune | CYCLOSPORINE | Novartis Pharmaceuticals Corporation | 5e5926a7-1de0-4b54-a5c0-286b6200ff82 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | CYCLOSPORINE |
| CEQUA | CYCLOSPORINE | Sun Pharmaceutical Industries, Inc. | 48c3d8a3-4289-4b52-9189-58b48596095c | 2026-06-15 | Warnings, Adverse reactions | CYCLOSPORINE |
| Verkazia | CYCLOSPORINE | Harrow Eye, LLC | 48651d30-9e6e-74b0-e063-6294a90a8337 | 2026-06-03 | Warnings, Adverse reactions | CYCLOSPORINE |
| CYCLOSPORINE | CYCLOSPORINE | Upsher-Smith Laboratories, LLC | f7e4a2f0-ea2a-449b-bc6d-a6ea3d47b850 | 2026-05-22 | Warnings, Adverse reactions | CYCLOSPORINE CYCLOSPORINE |
| Cyclosporine | CYCLOSPORINE | Apotex Corp. | bfca7088-fe93-abb9-3ec3-e6f5710a69c6 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | Cyclosporine CYCLOSPORINE |
| CYCLOSPORINE | CYCLOSPORINE | Saptalis Pharmaceuticals, LLC | ff4dc2fc-667a-489a-b798-8d11cddfe716 | 2025-12-09 | Warnings, Adverse reactions | CYCLOSPORINE CYCLOSPORINE |
| CYCLOSPORINE | CYCLOSPORINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 1952d4c7-a40e-4924-b669-c41400774cb9 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | CYCLOSPORINE CYCLOSPORINE |
| CycloSPORINE, Modfied | CYCLOSPORINE | Apotex Corp. | 5baaf78c-90f6-abcf-52c8-814490f3cf9f | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | CYCLOSPORINE |
| Restasis MultiDose | CYCLOSPORINE | Allergan, Inc. | 7224d810-bb96-4682-a942-3355e6e8061a | 2025-08-21 | Warnings, Adverse reactions | CYCLOSPORINE |
| Cyclosporine | CYCLOSPORINE | Devatis Inc. | 7bb2078d-17c2-4e6a-9f61-26c7ecbce945 | 2025-02-17 | Warnings, Adverse reactions | Cyclosporine CYCLOSPORINE |
| Verkazia | CYCLOSPORINE | Santen Incorporated | c795cd2f-89da-78e3-e053-2a95a90a9422 | 2025-01-17 | Warnings, Adverse reactions | CYCLOSPORINE |
| Cyclosporine | CYCLOSPORINE | Apotex Corp | 70c8a4a6-ebe2-457f-a626-400c338cec2d | 2024-09-23 | Warnings, Adverse reactions | Cyclosporine CYCLOSPORINE |
| Cyclosporine | CYCLOSPORINE | KVK-TECH, INC. | a7040dc6-063b-40ee-8f2a-153e87b08430 | 2024-09-23 | Warnings, Adverse reactions | Cyclosporine CYCLOSPORINE |
| RESTASIS | CYCLOSPORINE | Allergan, Inc. | 8e24af2b-bc1c-4849-94f2-6df950cdca89 | 2024-09-09 | Warnings, Adverse reactions | CYCLOSPORINE |
| CYCLOSPORINE | CYCLOSPORINE | Lupin Pharmaceuticals, Inc. | 9aca2026-af86-4e97-925e-c202b87c46ac | 2024-09-01 | Warnings, Adverse reactions | CYCLOSPORINE CYCLOSPORINE |
| Gengraf | CYCLOSPORINE | AbbVie Inc. | e896cbfe-4745-4088-82a3-8dc10b75c41f | 2024-08-21 | Boxed warning, Warnings, Adverse reactions | CYCLOSPORINE |
| Cyclosporine | CYCLOSPORINE | Teva Pharmaceuticals USA, Inc. | f3dc2a50-1084-4190-a6f3-37034a04db86 | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | Cyclosporine CYCLOSPORINE |
| Cyclosporine | CYCLOSPORINE | Dr. Reddy's Laboratories Inc | 64ec430a-e930-145c-e766-13fb49b64644 | 2024-06-03 | Boxed warning, Warnings, Adverse reactions | Cyclosporine CYCLOSPORINE |
| RESTASIS | CYCLOSPORINE | A-S Medication Solutions | ee57c1c0-2fcd-4628-8e33-4e0a9dadcb03 | 2024-05-24 | Warnings, Adverse reactions | CYCLOSPORINE |